Principal Financial Group Inc. Purchases 46,833 Shares of Encompass Health Co. (NYSE:EHC)

Principal Financial Group Inc. raised its position in Encompass Health Co. (NYSE:EHCGet Rating) by 13.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 392,787 shares of the company’s stock after purchasing an additional 46,833 shares during the period. Principal Financial Group Inc. owned 0.39% of Encompass Health worth $22,016,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of EHC. Baupost Group LLC MA boosted its holdings in Encompass Health by 318.9% in the 1st quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock valued at $213,330,000 after purchasing an additional 2,283,900 shares during the period. Empyrean Capital Partners LP bought a new position in Encompass Health in the 1st quarter valued at $81,506,000. Paradice Investment Management LLC bought a new stake in shares of Encompass Health during the 1st quarter worth $47,388,000. Victory Capital Management Inc. lifted its holdings in shares of Encompass Health by 40.0% during the 2nd quarter. Victory Capital Management Inc. now owns 2,146,910 shares of the company’s stock worth $120,335,000 after acquiring an additional 613,547 shares during the last quarter. Finally, Glenview Capital Management LLC lifted its holdings in shares of Encompass Health by 72.8% during the 1st quarter. Glenview Capital Management LLC now owns 1,285,534 shares of the company’s stock worth $91,414,000 after acquiring an additional 541,736 shares during the last quarter. 93.07% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Credit Suisse Group dropped their price objective on shares of Encompass Health from $63.00 to $62.00 and set an “outperform” rating for the company in a report on Wednesday, September 21st. StockNews.com began coverage on shares of Encompass Health in a research report on Wednesday, October 12th. They issued a “hold” rating on the stock. Barclays decreased their target price on shares of Encompass Health from $80.00 to $63.00 and set an “overweight” rating on the stock in a research report on Thursday, August 4th. Stephens decreased their target price on shares of Encompass Health from $60.00 to $58.00 and set an “overweight” rating on the stock in a research report on Friday, October 28th. Finally, Royal Bank of Canada decreased their target price on shares of Encompass Health from $82.00 to $66.00 in a research report on Wednesday, August 24th. One investment analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $64.13.

Encompass Health Price Performance

EHC stock opened at $56.00 on Monday. The firm’s 50-day moving average price is $50.92 and its two-hundred day moving average price is $53.72. Encompass Health Co. has a 12-month low of $44.33 and a 12-month high of $74.61. The stock has a market capitalization of $5.59 billion, a price-to-earnings ratio of 20.59, a PEG ratio of 2.72 and a beta of 1.06. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 1.59.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 17th. Shareholders of record on Tuesday, January 3rd will be given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date of this dividend is Friday, December 30th. Encompass Health’s payout ratio is 22.06%.

Insider Buying and Selling at Encompass Health

In other news, Director Greg D. Carmichael acquired 1,830 shares of the firm’s stock in a transaction on Monday, October 31st. The shares were purchased at an average price of $54.67 per share, for a total transaction of $100,046.10. Following the completion of the transaction, the director now owns 10,546 shares of the company’s stock, valued at $576,549.82. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 2.70% of the company’s stock.

Encompass Health Company Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Read More

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCGet Rating).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.